变异异基因频率:精密瘤学的决策工具?
Luca Boscolo Bielo1, Dario Trapani1, Matteo Repetto2
1Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Trends in cancer
|September 13, 2023
概括
变异性等位基频率 (VAF) 作为精确瘤学的预测生物标志物,有望为选择向疗法提供帮助. 需要进一步验证以标准化其临床使用.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 生物标志物发现发现
背景情况:
- 精确瘤学依赖于预测生物标志物来选择向治疗.
- 变异基频率 (VAF) 提供了对瘤克隆性和主要癌细胞种群的见解.
研究的目的:
- 审查VAF作为预测生物标志物的证据.
- 讨论VAF在向治疗选择中的临床实施的挑战和机会.
主要方法:
- 对VAF的预后和预测作用现有研究的审查.
- 分析VAF在体内基因组测试中的实用性.
主要成果:
- VAF已经证明了在识别可向的癌细胞种群方面的潜力.
- 目前的局限性包括缺乏验证的VAF值和试验标准化.
结论:
- 作为精确瘤学中的预测生物标志物,VAF具有前景.
- 进一步的分析和临床验证对于其广泛的临床实用性至关重要.
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Hardy-Weinberg Principle
72.3K
Diploid organisms have two alleles of each gene, one from each parent, in their somatic cells. Therefore, each individual contributes two alleles to the gene pool of the population. The gene pool of a population is the sum of every allele of all genes within that population and has some degree of variation. Genetic variation is typically expressed as a relative frequency, which is the percentage of the total population that has a given allele, genotype or phenotype.
72.3K


